Blood Safety Monitoring among Persons with Bleeding Disorders -United States, May 1998-June 2002

Morbidity and Mortality Weekly Report

Volumn 51, Issue 51-52, 2003, Pages 1152-1154

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR;

ARTICLE; BLEEDING DISORDER; BLOOD TRANSFUSION; BLOODBORNE BACTERIUM; DISEASE TRANSMISSION; HEMOPHILIA A; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; OUTPATIENT DEPARTMENT; SAFETY; UNITED STATES; VIRUS HEPATITIS;

AMBULATORY CARE FACILITIES; BLOOD COAGULATION FACTORS; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; HEMOPHILIA A; HEMORRHAGIC DISORDERS; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HUMANS; SAFETY; UNITED STATES;

EID: 0037415123     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Kao HW, Ashcavai M, Redeker AG. The persistence of hepatitis A IgM antibody after acute clinical hepatitis A. Hepatology 1984;4:933-6.
2. Soucie JM, Jackson D, Evatt B. The occurrence of hemophilia in the United States. Am J Hematol 1998;59:288-94.
3. Gjerset GF, Clements MJ, Counts RB, Halvorsen AS, Thompson AR. Treatment type and amount influenced human immunodeficiency virus seroprevalence of patients with congenital bleeding disorders. Blood 1991;78:1623-7.
4. Kasper CK, Kipnis SA. Hepatitis and clotting factor concentrates. JAMA 1972;221:510.
5. Mannucci PM, Gdovin S, Gringeri A, et al. Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. Ann Intern Med 1994;120:1-7.
6. Soucie JM, Robertson BH, Bell BP, McCaustland KA, Evatt BL. Hepatitis A virus infections associated with clotting factor concentrate in the United States. Transfusion 1998;38:573-9.
7. Kisker CT, Mahoney EM, Arkin S, Maeder MA, Donfield SM, Evatt BL. Changes in hepatitis B serologic titers in HIV+ and HIV- children with hemophilia. Hemophilia 1999;5:354-9.
8. Richardson LC, Evatt BL. Risk of hepatitis A virus in persons with hemophilia receiving plasma-derived products. Transfusion 2000;14:64-73.
9. CDC. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee. MMWR 1991;40(No. RR-13).
10. CDC. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices. MMWR 1999;48(No. RR-12).